Acknowledging the Complexity of Antipsychotic Use in Long-Term Care During the COVID-19 Pandemic.

IF 2.4 Q2 HEALTH CARE SCIENCES & SERVICES

Health Services Insights Pub Date : 2023-09-19 eCollection Date: 2023-01-01 DOI:10.1177/11786329231195211

Luke Andrew Turcotte, Caitlin McArthur, Jeff W Poss, George Heckman, Lori Mitchell, John Morris, Andrea D Foebel, John P Hirdes

{"title":"Acknowledging the Complexity of Antipsychotic Use in Long-Term Care During the COVID-19 Pandemic.","authors":"Luke Andrew Turcotte, Caitlin McArthur, Jeff W Poss, George Heckman, Lori Mitchell, John Morris, Andrea D Foebel, John P Hirdes","doi":"10.1177/11786329231195211","DOIUrl":null,"url":null,"abstract":"that an increase in administration also occurred in the previous year among Alberta residents. Our analysis was a comparison of the pandemic period against the 2 most recent historical years and did not test for year-over-year trends. Interrupted time series analysis by Hoben et al 3 supports Dr. Quail’s argument that the inappropriate use of antipsychotic medications increased in the years leading up to the pandemic in Alberta. However, in alignment with our own findings, the rate of that increase accelerated significantly during the pandemic period. We offer supplemental analysis of pairwise comparisons back to 2013/2014 when Alberta was first included in the annual CIHI “Quick Stats” report (Figure 1). This illustrates that (1) the increase during the pandemic period was significant relative to all years since 2014/2015 and (2) the magnitude of the increase observed in recent years was largest during the pandemic period. Without question, a greater percentage of residents received inappropriate antipsychotic medications during the pandemic period.","PeriodicalId":12876,"journal":{"name":"Health Services Insights","volume":"16 ","pages":"11786329231195211"},"PeriodicalIF":2.4000,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/92/88/10.1177_11786329231195211.PMC10510341.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Services Insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11786329231195211","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

that an increase in administration also occurred in the previous year among Alberta residents. Our analysis was a comparison of the pandemic period against the 2 most recent historical years and did not test for year-over-year trends. Interrupted time series analysis by Hoben et al 3 supports Dr. Quail’s argument that the inappropriate use of antipsychotic medications increased in the years leading up to the pandemic in Alberta. However, in alignment with our own findings, the rate of that increase accelerated significantly during the pandemic period. We offer supplemental analysis of pairwise comparisons back to 2013/2014 when Alberta was first included in the annual CIHI “Quick Stats” report (Figure 1). This illustrates that (1) the increase during the pandemic period was significant relative to all years since 2014/2015 and (2) the magnitude of the increase observed in recent years was largest during the pandemic period. Without question, a greater percentage of residents received inappropriate antipsychotic medications during the pandemic period.

Abstract Image